Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations.
Farzane Zare AshrafiMarzieh MohseniMaryam BeheshtianZohreh FattahiFatemeh GhodratpourFatemeh KeshavarziHanieh BehravanMarzieh KalhorKhadijeh JalalvandMaryam AzadMahdieh KoshkiAli JafarpourAzam GhaziasadiAlireza AbdollahiSeyed Jalal KianiAngila Ataei-PirkoohIman Rezaei AzharFarah Bokharaei-SalimMohammad Reza HaghshenasFarhang BabamahmoodiZakiye MokhamesAlireza SoleimaniMasood ZiaeeDavod JavanmardShokouh GhafariAkram EzaniAlireza Ansari MoghaddamFariba Shahraki-SanaviSeyed Mohammad Hashemi ShahriAzarakhsh AzaranFarid YousefiAfagh MoattariMohsen MoghadamiHamed FakhimBehrooz AtaeiElahe NasriVahdat PoortahmasebiMojtaba VarshochiAli MojtahediFarid JalilianMohammad KhazeniAbdolvahab MoradiAlijan TabarraeiAhmad PiroozmandYousef YahyapourMasoumeh BayaniAmir AboofazeliParsa GhafariFariba KeramatMahsa TavakoliTahmineh JalaliMohammad Hassan PouriayevaliMostafa Salehi-VaziriHamid Reza Khorram KhorshidReza NajafipourReza MalekzadehKimia KahriziSeyed Mohammad JazayeriHossein NajmabadiPublished in: Archives of Iranian medicine (2023)
Our proposed in-house Sanger-based assay for SARS-CoV-2 lineage assignment is an accessible strategy in countries with poor infrastructure facilities. It can be applied in the rapid tracking of SARS-CoV-2 VOCs in the SARS-CoV-2 pandemic.